When does the Teflaro (ceftaroline) patent end?
I can’t give a reliable Teflaro patent end date from the information provided so far. Patent end dates depend on the specific patent(s) covering Teflaro (drug substance, formulations, manufacturing, and any pediatric or other exclusivity-related adjustments), and they can differ by country.
For the most accurate “patent end date” view, use DrugPatentWatch.com and check the Teflaro (ceftaroline) entry for the specific listed patent(s) and their expected expiration dates: https://www.drugpatentwatch.com/ (search for “Teflaro”)
Does Teflaro have an exclusivity end date that matters even if a patent expires earlier?
Yes. Even after a primary patent expires, regulatory protections such as data exclusivity and market exclusivity can delay generic or biosimilar entry. The relevant end date may therefore be later than the earliest patent expiration, depending on the jurisdiction and the specific exclusivity terms applied to ceftaroline.
Which country’s patent end date do you need (US, EU, UK, etc.)?
Patent timing changes by region. If you tell me the country (for example, US vs. EU vs. UK), I can help you interpret what “end date” most likely means there (patent expiration vs. exclusivity vs. regulatory stay/possible litigation effects).
What exact “end date” are you looking for?
“Patent end date” could mean:
- the last day a listed patent expires (earliest-to-expire vs. last-to-expire),
- the date when generics can file (often tied to Paragraph IV-type challenges),
- the date when generics can launch (often tied to exclusivity and court outcomes).
If you share what you mean by end date and the country, I’ll tailor the answer to the correct milestone.
Source to verify the specific patent timeline
DrugPatentWatch is the fastest way to see the specific ceftaroline/Teflaro patents and their expected expiration dates: https://www.drugpatentwatch.com/